期刊文献+

双侧卵巢巨大子宫内膜异位囊肿误诊及文献复习

Misdiagnosis and literature review of giant endometriosis cyst of bilateral ovary
下载PDF
导出
摘要 目的分析1例双侧卵巢子宫内膜异位囊肿术前误诊的相关因素,HE4检测对上皮性卵巢恶性肿瘤诊断的价值,提高该病的术前诊断准确率,为制定手术计划、判断预后提供依据。方法回顾性分析本院2019年8月收治的1例巨大双侧子宫内膜异位囊肿患者的临床表现、CT等影像学检查、肿瘤标志物检查、术前诊断、术中所见、术后病理等,探讨总结误诊的原因。结果术前腹部CT检查显示:腹腔、盆腔多发囊实混合性占位性病变,考虑恶性肿瘤性病变。术前两次CA125分别为:2128 U/mL、3637 U/mL,HE4分别为>1500 U/mL、316.4 U/mL,体检:腹膨隆,脐上4横指触及一巨大囊实性肿物。2019年8月15日在喉罩全麻下“经腹双侧附件切除+盆腔巨大肿物切除+全子宫切除+阴道顶悬吊术+大网膜切除+重度盆腔粘连松解术”。术后病理结果显示:子宫内膜样囊肿。结论生育龄妇女患者盆腹腔巨大囊实性肿物,术前两次CA125检查呈上升趋势,但HE4明显下降,提示HE4检测可用于卵巢良恶性肿瘤的鉴别诊断。 Objective To analyze the related factors of misdiagnosis of bilateral ovarian endometriosis cyst before operation.To analyze the value of HE4 detection in the diagnosis of epithelial ovarian cancer.Improve the accuracy of preoperative diagnosis of the disease.To provide basis for making operation plan and judging prognosis.Methods Retrospective analysis of a case of huge bilateral endometriosis cyst in August 2019 in our hospital,According to the clinical manifestations of patients,CT and other imaging examination,tumor marker examination,preoperative diagnosis,intraoperative findings,postoperative pathology,etc.Discuss and summarize the causes of misdiagnosis.Results Preoperative CT findings of abdomen in our hospital:Multiple space occupying lesions of abdominal cavity and pelvic cavity,which were considered malignant lesions.CA125 were 2128 U/mL,3637 U/mL,HE4 were>1500 U/mL,316.4 U/mL respectively before operation.Physical examination:abdominal bulge,a huge cystic solid mass was touched by the 4 transverse fingers on the umbilicus.On August 15,2019,under general anesthesia with a laryngeal mask,the patient underwent"Transabdominal excision of bilateral adnexa of uterus,excision of giant pelvic masses,total hysterectomy,vaginal ceiling suspension,omentectomy,and lysis of severe pelvic adhesion."Postoperative pathological results showed that endometrioid cyst.Conclusion Huge cystic solid mass in pelvic and abdominal cavity of women of childbearing age,CA125 examinations twice showed upward trend before operation,however,HE4 decreased significantly,to summarize,HE4 detection can be used in the differential diagnosis of ovarian benign and malignant tumors.
作者 陈志琴 高玉玲 李文洲 董洁琼 CHEN Zhiqin;GAO Yuling;LIWenzhou;DONG Jieqiong(Department of Gynaecology and Obstetrics,Fujian Medical University Provincial College of Clinical Medicine,Fuzhou,Fujian,350001,China)
出处 《当代医学》 2021年第7期1-3,共3页 Contemporary Medicine
关键词 子宫内膜异位囊肿 卵巢恶性肿瘤 CA125 HE4 Endometriosis cyst Ovarian malignant tumor Carbohydrate antigen 125 Human epididymis protein 4
  • 相关文献

参考文献5

二级参考文献58

  • 1Galgano MTC, Hampton GM,Frierson HF Jr,et al. Com- prehensive analysis of HE4 expression in normal and ma- lignant human tissues[J]. Modern Pathology, 2006, 19 (6) :847-853. 被引量:1
  • 2Molina R, Escudero JM, Auge JM, et al. HE4 a novel turnout marker for ovarian cancer., comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases[J]. Tumor Biol,2011,32(6) ;1087-1095. 被引量:1
  • 3Drapkin R, von Horsten H H, Lin Y, et al. Human epidid- ymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carci- nomas[J]. Cancer Res,2005,65(6) :2162-2169. 被引量:1
  • 4Anton C, Carvalho FM, Oliveira EI, et al. A comparison of CA125, HE4, risk ovarian malignancy algorithm (RO- MA) ,and risk malignancy index(RMI) for the classifica- tion of ovarian masses[J]. Clinics,2012,67(5) :437-441. 被引量:1
  • 5Azzam AZ, Hashad DI, Kamel NA, et al. Evaluation of HE4 as an extrabiomarker to CA125 to improve detection of ovarian carcinoma: is it time for a step forward[J]. Arch Gynecol Obstet, 2013,288( 1 ): 167-172. 被引量:1
  • 6Hamed EO, Ahmed H, Sedeek OB, et al. Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response[J]. Diagn Pathol, 2013-01-23[2013-12-27], http://www, nc- hi. nlm. nih. gov/pubmed/23343214. 被引量:1
  • 7Kalapotharakos G, Asciutto C, Henic E, et al. High preop- erative blood levels of HE4 predicts poor prognosis in pa- tients with ovarian eancer[J]. J Ovarian Res, 2012,5 (1) : 20-24. 被引量:1
  • 8Plotti F,Capriglione S,Terranova C, et al. Does HE4 have a role as biomarker in the recurrence of ovarian cancer [J]. Tumor Biol,2012,33(6) :2117-2123. 被引量:1
  • 9Zheng H, Gao Y. Serum HE4 as a useful biomarker in discriminating ovarian cancer from benign pelvic disease [J]. Int J Gynecol Cancer,2012,22(6) :1000-1005. 被引量:1
  • 10Moore RG,Brown AK, Miller MC, et al. The use of mul- tiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass[J]. Gynecol On- col, 2008,108 (2) : 402-408. 被引量:1

共引文献1215

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部